Rare diseases
Investigational molecules
Locations
Back to Germany290 clinical trials in Aachen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
GermanyStudy of GSK5733584 versus paclitaxel or doxorubicin in patients with advanced or recurrent endometrial cancer after platinum‑based chemotherapy and immunotherapy
GermanyStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
GermanyNon‑inferiority study of autologous minced cartilage and autologous cultured chondrocytes in adults with large full‑thickness knee cartilage defects
GermanySafety and Tolerability of Lutetium‑177 Vipivotide Tetraxetan Combined with Gozetotide in Women with Metastatic Triple‑Negative Breast Cancer
GermanyStudy of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia
GermanyEfficacy of asciminib in chronic phase chronic myeloid leukemia patients with T315I mutation
GermanyShortening treatment duration in adults with uncomplicated candidemia: caspofungin acetate versus saline and sodium lactate placebo
GermanyAngiotensin II in Children and Adolescents With Refractory Hypotension in Distributive Shock
GermanyA study to evaluate the effectiveness and safety of AP707 in patients with borderline personality disorder.
GermanyComparing two treatment regimens with drug combination for newly diagnosed low-risk medulloblastoma to evaluate cognitive function outcomes
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma treatments and various forms of breast cancer therapies, including studies of novel immunotherapy combinations for head and neck cancers.
Advanced therapeutic approaches including targeted treatments and combination therapies are being evaluated for improved patient outcomes.
Research targeting heart failure prevention and management of cardiovascular complications, with emphasis on innovative drug combinations and preventive treatments.
Studies focus on reducing cardiovascular events and improving long-term patient outcomes.
Clinical investigations addressing various chronic conditions, including inflammatory diseases and dermatological disorders.
Evaluating new therapeutic approaches for managing long-term conditions and improving quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
